Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation

IF 4.5 2区医学 Q1 HEMATOLOGY Bone Marrow Transplantation Pub Date : 2024-08-26 DOI:10.1038/s41409-024-02405-0

Shigeo Fuji, Hirohisa Nakamae, Junichi Sugita, Yuho Najima, Tatsuya Konishi, Takashi Tanaka, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Kazutaka Nakayama, Ayumu Ito, Makoto Yoshimitsu, Masayuki Hino, Takahiro Fukuda, Yoshiko Atsuta, Kimikazu Yakushijin

引用次数: 0

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

在单倍体造血细胞移植中降低移植后环磷酰胺的剂量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.

期刊最新文献

Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT. The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience. Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice. The role of daratumumab in complications post-allogeneic hematopoietic stem cell transplantation: a single-center prospective study on PRCA and AIHA. High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study.